COLUMBIA-AAAU4206-AIRPANC
Phase II
OPEN TO ACCRUAL
A Phase 2 , Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination with Immune Checkpoint Blockade and Radiation Therapy in Patients with Advanced PANCreatic Ductal Adenocarcinoma Who Are Candidates For Surgical Resection
IIT-HALL-SOFT-PRE-OP
Phase II
OPEN TO ACCRUAL
A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
IIT-TSAI-PANC
Phase II
OPEN TO ACCRUAL
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients with Localized Pancreatic Cancer
IIT-TSAI-PANCREAS-TRIAL
Phase II
OPEN TO ACCRUAL
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS SAmples Study
NRG-GY022
Phase I
OPEN TO ACCRUAL
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin